Module 4: Genetic dyslipidaemias diagnosis and treatment
Speaker: Robert Hegele, London, Ontario, Canada
About the talk:
The human genome project has allowed reclassification of genetic dyslipidemias – including hypercholesterolemia and hypertriglyceridemia – providing a framework for diagnostic next-generation sequencing.
About the speaker:
Rob Hegele is a Distinguished Professor of Medicine and Biochemistry at Western University in London, Ontario, Canada. He cares for >2500 patients in his lipid clinic. His laboratory discovered the genes that cause >20 human diseases. He was among the first in the world to use five medications that are now routinely prescribed to treat dyslipidemia or diabetes. He has published >870 papers, and is in the top 1% of highly cited scientists in the world. The website Expertscape.com in 2022 ranked him #1 globally in the area of “hypertriglyceridemia” and #2 for “disorders of lipid metabolism”. He received the 2019 American Heart Association Lyman Duff Award and the 2020 FH Foundation Pioneer Award. He has co-authored many clinical practice guidelines for cholesterol, blood pressure and diabetes. He has trained numerous physicians, medical students and graduate students.